Back to search

Article

Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Long-Term Results of a Prospective Phase II Study

2023-07-07

Abstract excerpt

The optimal therapy for patients with non-metastatic biochemically relapsed prostate cancer (BRPC-M0) after local therapy is elusive. Thus, the evaluation of new non-toxic compounds in BRPC-M0 patients is warranted. PectaSol® modified citrus pectin (P-MCP) is a food supplement generally recognized as safe (GRAS) by the Food and Drug Administration (FDA) and is a competitive inhibitor of galectin-3 protein, involve...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1754d4a0-83dc-54bd-aeb3-ecaa8deb8a86
DOI
10.20944/preprints202307.0475.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 8 closest
Select a neighboring publication to make it the new centre.